These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1920850)

  • 1. [Blood transfusion and transplantation].
    Ishikura H; Endo J
    Rinsho Byori; 1991 Jul; Suppl 90():139-50. PubMed ID: 1920850
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.
    Mehta J; Powles R; Singhal S; Horton C; Hamblin M; Zomas A; Saso R; Treleaven J
    Bone Marrow Transplant; 1996 Jul; 18(1):151-6. PubMed ID: 8832008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchange for bone marrow transplantation.
    Ho W
    Prog Clin Biol Res; 1982; 88():287-94. PubMed ID: 7048328
    [No Abstract]   [Full Text] [Related]  

  • 5. Is the ABO incompatibility a risk factor in bone marrow transplantation?
    Rozman P; Kosir A; Bohinjec M
    Transpl Immunol; 2005 Aug; 14(3-4):159-69. PubMed ID: 15982558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation: the role of immunohematologic services.
    Myers JA
    Clin Lab Sci; 1990; 3(5):316-9. PubMed ID: 10150040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of transfusion-associated graft-vs-host disease.
    Holland PV
    Arch Pathol Lab Med; 1989 Mar; 113(3):285-91. PubMed ID: 2645855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
    Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion-associated graft-versus-host disease in a newborn.
    Ozdoğan T; Metin F; Doğu A; Timur C; Yildiz E
    J Matern Fetal Neonatal Med; 2007 Mar; 20(3):271-2. PubMed ID: 17450462
    [No Abstract]   [Full Text] [Related]  

  • 10. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
    Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
    Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
    Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
    Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
    Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone marrow transplantation with major ABO incompatibility. Experience at the bone marrow transplantation unit of the Center of Lisbon at the IPOFG].
    Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
    Acta Med Port; 1993 Feb; 6(2):79-81. PubMed ID: 8488766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auto anti-A1 and auto anti-NA1 after bone marrow transplantation.
    Herzog P; Korínková P; Stambergová M; Lukásová M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(6):874-80. PubMed ID: 2453418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-associated graft-versus-host disease.
    Rühl H; Bein G; Sachs UJ
    Transfus Med Rev; 2009 Jan; 23(1):62-71. PubMed ID: 19056035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probable graft-vs-graft reaction in an infant after exchange transfusion and marrow transplantation.
    Lauer BA; Githens JH; Hayward AR; Conrad PD; Yanagihara RT; Tubergen DG
    Pediatrics; 1982 Jul; 70(1):43-7. PubMed ID: 6806770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Posttransfusion graft vs host disease].
    Muñoz MC; Hernández M; Rifón J; Panizo C; Rodríguez M
    Sangre (Barc); 1998 Feb; 43(1):55-8. PubMed ID: 9580428
    [No Abstract]   [Full Text] [Related]  

  • 18. ABO histo-blood group system-incompatible allografting.
    Nydegger U; Mohacsi P; Koestner S; Kappeler A; Schaffner T; Carrel T
    Int Immunopharmacol; 2005 Jan; 5(1):147-53. PubMed ID: 15589475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new concept of accommodation in ABO-incompatible kidney transplantation.
    Takahashi K
    Clin Transplant; 2005; 19 Suppl 14():76-85. PubMed ID: 15955174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings.
    Mehta J; Powles R; Horton C; Milan S; Singhal S; Treleaven J
    Bone Marrow Transplant; 1995 Jun; 15(6):853-8. PubMed ID: 7581080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.